3 papers in the library · publishing 2026
OSF Preprints (OSF Preprints) September 10, 2026 Bartosz Helfer, Katarzyna Henke‐Ciążyńska, Daniel Pankowski et al. preprint
The original data comprise the extraction, coding, identity mappings and appraisals produced for the accompanying meta-research study. Their source material is previously published literature.
International Journal of Neuropsychopharmacology September 9, 2026 K Henke-Ciążyńska, D Pankowski, B Helfer
Abstract Background Systematic reviews with meta-analyses (SR-MAs) of psychedelic-assisted psychotherapy (PAP) guide clinical and policy decisions. Their trustworthiness depends, in part, on how consistently different SR-MAs assess risk of bias (RoB) in the same underlying randomized controlled trials (RCTs), and how transparently those judgments are justified. Aims & Objectives To summarise...
Open MIND 2026 Katarzyna Korsak, Daniel Pankowski, Paweł Holas
The clinical use of psychedelic substances and Psychedelic-Assisted Therapy (PAT) is an area of growing interest that also raises significant social concerns and controversy. Despite existing legal restrictions, empirical research on substances such as psilocybin, mescaline, MDMA, LSD, DMT, and ibogaine has been developing, particularly in the treatment of conditions such as treatment-resistant...